Literature DB >> 7826280

Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

L M Bierer1, P R Hof, D P Purohit, L Carlin, J Schmeidler, K L Davis, D P Perl.   

Abstract

OBJECTIVE: To determine the relationships between dementia severity and the extent of histopathologic lesions in a variety of brain regions. Neocortical and hippocampal ratings for neurofibrillary tangles (NFTs) and senile plaques (SPs) were compared in 70 cases of clinically and neuropathologically confirmed Alzheimer's disease.
DESIGN: Neuropathologic case series. Dementia severity was assessed by postmortem chart review with use of the extended Clinical Dementia Rating Scale (CDR). Linear association between CDR scores and NFT and SP scores were assessed by partial correlation, controlling for age at death.
SETTING: Studies were conducted at the Alzheimer's Disease Research Center of the Mount Sinai Medical Center, New York, NY. MAIN OUTCOME MEASURE: Association between CDR scores and neuropathologic changes assessed with the Consortium to Establish a Registry for Alzheimer's Disease semiquantitative scale.
RESULTS: Among these lesion scores, only NFTs showed a significant association with CDR score, and only for neocortical regions. In particular, NFT densities in the superior temporal cortex were most strongly correlated with dementia severity, followed by those in the inferior parietal and midfrontal cortex. No such correlations were apparent for the amygdala, hippocampus, or entorhinal cortex. Medial temporal lobe structures displayed high NFT scores, even in cases of mild dementia. Senile plaques did not correlate significantly with CDR score in any region.
CONCLUSIONS: These data support the notion that neocortical neuronal degeneration, as indicated by NFT formation, is a critical determinant of the clinical progression of Alzheimer's disease and suggest that medial temporal lobe structures may represent the initial site of NFT formation. While SP density correlates with age at death, there is no correlation between SP counts and dementia severity. These results further suggest that the clinical presentation of dementia may be closely related to neurodegeneration in neocortical regions within the temporal lobe.

Entities:  

Mesh:

Year:  1995        PMID: 7826280     DOI: 10.1001/archneur.1995.00540250089017

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  139 in total

1.  Building a more perfect beast: APP transgenic mice with neuronal loss.

Authors:  Dennis W Dickson
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

2.  Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.

Authors:  Sabine Ott; Andreas Wolfram Henkel; Maria Kerstin Henkel; Zoran B Redzic; Johannes Kornhuber; Jens Wiltfang
Journal:  Mol Cell Biochem       Date:  2010-11-27       Impact factor: 3.396

3.  Characterization of Japanese-American men with a single neocortical AD lesion type.

Authors:  Helen Petrovitch; G Webster Ross; Qimei He; Jane Uyehara-Lock; William Markesbery; Daron Davis; James Nelson; Kamal Masaki; Lenore Launer; Lon R White
Journal:  Neurobiol Aging       Date:  2007-05-17       Impact factor: 4.673

Review 4.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Authors:  J C Morris; J L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

5.  Translational gene mapping of cognitive decline.

Authors:  Beth Wilmot; Shannon K McWeeney; Randal R Nixon; Thomas J Montine; Jamie Laut; Christina A Harrington; Jeffrey A Kaye; Patricia L Kramer
Journal:  Neurobiol Aging       Date:  2006-12-14       Impact factor: 4.673

6.  Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.

Authors:  Christoph Laske; Elke Stransky; Andreas Fritsche; Gerhard W Eschweiler; Thomas Leyhe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

7.  Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

Authors:  Parvathi Rudrabhatla; Howard Jaffe; Harish C Pant
Journal:  FASEB J       Date:  2011-08-09       Impact factor: 5.191

8.  Modeling regional vulnerability to Alzheimer pathology.

Authors:  Donald R Royall; Raymond F Palmer; Helen Petrovitch; G Webster Ross; Kamal Masaki; Lon R White
Journal:  Neurobiol Aging       Date:  2011-07-30       Impact factor: 4.673

Review 9.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 10.  Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.

Authors:  Elvira Valera; Brian Spencer; Eliezer Masliah
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.